{"Title": "Prostate cancers that 'Wnt' respond to abiraterone", "Year": 2018, "Source": "Ann. Oncol.", "Volume": "29", "Issue": 2, "Art.No": null, "PageStart": 290, "PageEnd": 292, "CitedBy": 1, "DOI": "10.1093/annonc/mdx785", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042559651&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Abiraterone Acetate", "Androstenes", "Cell Cycle", "Cell Proliferation", "Genome-Wide Association Study", "Humans", "Male", "Prednisone", "Prospective Studies", "Prostatic Neoplasms, Castration-Resistant", "Wnt Signaling Pathway"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85042559651", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"]], "AuthorData": {"23489393000": {"Name": "Linch M.", "AuthorID": "23489393000", "AffiliationID": "60024544", "AffiliationName": "Department of Medical Oncology, UCLH"}, "9740870900": {"Name": "Attard G.", "AuthorID": "9740870900", "AffiliationID": "113051862", "AffiliationName": "The Royal Marsden"}}}